Free Trial

Landore Resources (LND) Competitors

Landore Resources logo
GBX 3.46 -0.04 (-1.14%)
(As of 11:37 AM ET)

LND vs. AVO, FDP, TED, CUSN, ATM, ZNWD, FAR, GSP, PYX, and ARCM

Should you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), Cornish Metals (CUSN), Andrada Mining (ATM), Zinnwald Lithium (ZNWD), Ferro-Alloy Resources (FAR), Gensource Potash (GSP), PYX Resources (PYX), and Arc Minerals (ARCM).

Landore Resources vs.

Advanced Oncotherapy (LON:AVO) and Landore Resources (LON:LND) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

17.8% of Advanced Oncotherapy shares are owned by institutional investors. Comparatively, 3.2% of Landore Resources shares are owned by institutional investors. 47.5% of Advanced Oncotherapy shares are owned by insiders. Comparatively, 39.6% of Landore Resources shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Landore Resources had 1 more articles in the media than Advanced Oncotherapy. MarketBeat recorded 1 mentions for Landore Resources and 0 mentions for Advanced Oncotherapy. Landore Resources' average media sentiment score of 0.67 beat Advanced Oncotherapy's score of 0.00 indicating that Landore Resources is being referred to more favorably in the news media.

Company Overall Sentiment
Advanced Oncotherapy Neutral
Landore Resources Positive

Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced OncotherapyN/AN/A-£32.60M-£0.07-25.00
Landore ResourcesN/AN/A-£1.77M-£0.01-350.00

Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced OncotherapyN/A -67.34% -11.73%
Landore Resources N/A -207.95%-106.31%

Advanced Oncotherapy has a beta of 0.06, indicating that its stock price is 94% less volatile than the S&P 500. Comparatively, Landore Resources has a beta of -0.15, indicating that its stock price is 115% less volatile than the S&P 500.

Advanced Oncotherapy received 122 more outperform votes than Landore Resources when rated by MarketBeat users. Likewise, 60.97% of users gave Advanced Oncotherapy an outperform vote while only 57.76% of users gave Landore Resources an outperform vote.

CompanyUnderperformOutperform
Advanced OncotherapyOutperform Votes
189
60.97%
Underperform Votes
121
39.03%
Landore ResourcesOutperform Votes
67
57.76%
Underperform Votes
49
42.24%

Summary

Advanced Oncotherapy beats Landore Resources on 8 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LND vs. The Competition

MetricLandore ResourcesOther Industrial Metals & Mining IndustryMaterials SectorLON Exchange
Market Cap£10.95M£865.33M£2.81B£1.38B
Dividend Yield6.74%6.46%5.26%11.73%
P/E Ratio-350.0085.88111.951,551.35
Price / SalesN/A53,922.99591,179.79209,189.85
Price / Cash21.0024.4623.1532.93
Price / Book3.502.543.342.80
Net Income-£1.77M£56.06M£149.36M£152.70M
7 Day Performance-1.99%0.67%0.62%-0.54%
1 Month Performance-8.85%-4.88%1.41%7.07%
1 Year Performance-41.96%33.72%27.46%91.74%

Landore Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LND
Landore Resources
N/AGBX 3.46
-1.1%
N/A-43.7%£10.82MN/A-346.006Gap Down
AVO
Advanced Oncotherapy
N/AGBX 1.75
-9.1%
N/AN/A£9.50MN/A-25.003,900Gap Down
FDP
FD Technologies
N/AGBX 1,744
+0.6%
N/A+79.9%£492.16M£248.86M-3,612.5040,100Gap Down
TED
Ted Baker
N/AGBX 109.80
flat
N/A+0.0%£202.71M£428.24M-5.69740
CUSN
Cornish Metals
N/AGBX 7.90
-3.7%
N/A-23.4%£42.29MN/A1,150.00N/AGap Down
ATM
Andrada Mining
1.5904 of 5 stars
GBX 2.44
+1.8%
GBX 10
+309.2%
-57.9%£40.33M£17.97M-240.00219Gap Up
ZNWD
Zinnwald Lithium
N/AGBX 7.20
-0.7%
N/A-11.6%£34.17MN/A-825.0023Gap Up
FAR
Ferro-Alloy Resources
N/AGBX 6.50
+176.6%
N/A-72.6%£31.41M£4.55M-680.001,000Analyst Forecast
Gap Up
High Trading Volume
GSP
Gensource Potash
N/AGBX 5.25
flat
N/AN/A£23.61MN/A-525.00N/A
PYX
PYX Resources
N/AGBX 4.36
+10.4%
N/A-73.5%£20.10M£21.43M-325.0095Gap Up
High Trading Volume
ARCM
Arc Minerals
N/AGBX 1.34
-0.4%
N/A-62.2%£19.49MN/A-307.5035

Related Companies and Tools


This page (LON:LND) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners